Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Amyotrophic lateral sclerosis (ALS) | Q8NDH6-2 | 0 | chlorzoxazone | 4032 | drug-path |
Epithelial cell signaling in Helicobacter pylori infection | 0 | map05120 | chlorzoxazone | 4032 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | chlorzoxazone | 4032 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | scopolamine N-oxide | 3000667 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | scopolamine N-oxide | 3000667 | drug-path |
Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | scopolamine N-oxide | 3000667 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | antimycin A | 5284585 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | antimycin A | 5284585 | drug-path |
Chemokine signaling pathway | R-HSA-168638 | map04062 | antimycin A | 5284585 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | antimycin A | 5284585 | drug-path |
Jak-STAT signaling pathway | R-HSA-168638 | map04630 | antimycin A | 5284585 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | antimycin A | 5284585 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | antimycin A | 5284585 | drug-path |
Small cell lung cancer | R-HSA-5619066 | map05222 | H-89 | 135398740 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | H-89 | 135398740 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | cefmetazole | 42008 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | cefmetazole | 42008 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | cefmetazole | 42008 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | cefmetazole | 42008 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | cefmetazole | 42008 | drug-path |